494 related articles for article (PubMed ID: 32430154)
1. Hypolipidemia is associated with the severity of COVID-19.
Wei X; Zeng W; Su J; Wan H; Yu X; Cao X; Tan W; Wang H
J Clin Lipidol; 2020; 14(3):297-304. PubMed ID: 32430154
[TBL] [Abstract][Full Text] [Related]
2. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study.
Wang G; Zhang Q; Zhao X; Dong H; Wu C; Wu F; Yu B; Lv J; Zhang S; Wu G; Wu S; Wang X; Wu Y; Zhong Y
Lipids Health Dis; 2020 Sep; 19(1):204. PubMed ID: 32892746
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study.
Tanaka S; De Tymowski C; Assadi M; Zappella N; Jean-Baptiste S; Robert T; Peoc'h K; Lortat-Jacob B; Fontaine L; Bouzid D; Tran-Dinh A; Tashk P; Meilhac O; Montravers P
PLoS One; 2020; 15(9):e0239573. PubMed ID: 32970772
[TBL] [Abstract][Full Text] [Related]
4. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019.
Fan J; Wang H; Ye G; Cao X; Xu X; Tan W; Zhang Y
Metabolism; 2020 Jun; 107():154243. PubMed ID: 32320740
[TBL] [Abstract][Full Text] [Related]
5. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection.
Hu X; Chen D; Wu L; He G; Ye W
Clin Chim Acta; 2020 Nov; 510():105-110. PubMed ID: 32653486
[TBL] [Abstract][Full Text] [Related]
6. Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19).
Xie Y; You Q; Wu C; Cao S; Qu G; Yan X; Han X; Wang C; Zhang H
Circ J; 2020 Jul; 84(8):1277-1283. PubMed ID: 32536672
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study.
Yue J; Xu H; Zhou Y; Liu W; Han X; Mao Q; Li S; Tam LS; Ma J; Liu W
Front Endocrinol (Lausanne); 2021; 12():611526. PubMed ID: 34248834
[TBL] [Abstract][Full Text] [Related]
8. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
9. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of high-density lipoprotein in the evaluation of new coronavirus pneumonia.
Huang S; Zhou C; Yuan Z; Xiao H; Wu X
Adv Clin Exp Med; 2021 Feb; 30(2):153-156. PubMed ID: 33571404
[TBL] [Abstract][Full Text] [Related]
11. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
12. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
Yang M; Chen X; Xu Y
Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
[TBL] [Abstract][Full Text] [Related]
14. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
16. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
17. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
[TBL] [Abstract][Full Text] [Related]
18. HDL cholesterol levels and susceptibility to COVID-19.
Chidambaram V; Kumar A; Majella MG; Seth B; Sivakumar RK; Voruganti D; Bavineni M; Baghal A; Gates K; Kumari A; Al'Aref SJ; Galiatsatos P; Karakousis PC; Mehta JL
EBioMedicine; 2022 Aug; 82():104166. PubMed ID: 35843172
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
[TBL] [Abstract][Full Text] [Related]
20. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
